Вестибо Drug photo

The description is actual on 03.08.2014

  • Latin name: Vestibo
  • ATH code: N07CA01
  • Active ingredient: Betagistin (Betahistine)
  • Producer: Actavis Group hf. (Iceland)


Contains in Vestibo's tablets active agent of a betagistin of dihydrochloride. Depending on a dosage, one tablet contains 8,16 or 24 mg of active agent. Also tablets contain additional ingredients: MKTs, K90 povidone, monohydrate of lactose, colloid silicon dioxide, stearic acid, krospovidon, water.

Release form

Vestibo 8 mg are flat tablets which have slanted edges, the round form, whitish color, on the one hand on a tablet there is a marking of "B 8".

Vestibo of 16 mg — flat tablets which have slanted edges, the round form, whitish color, on the one hand on a tablet is marking of "B 16" on the other hand — risk.

Vestibo of 24 mg — biconvex tablets of whitish color, a round form, on the one hand — risk.

Pharmacological action

Betagistin, active agent of drug, is synthetic analog of a natural mediator of a histamine. The HP shows the expressed histamine activity in relation to H1 and H3 to receptors. Also active agent influences is vasodilating. Means exerts direct impact on a cochlear blood stream and a condition of a vestibular mechanism. Betagistin exerts impact on gistaminergichesky system which defines normal functions of vestibular systems.

Gistaminergichesky neurons are responsible for process of carrying out impulses from receptors and vestibular nuclei.

Under the influence of a betagistin the caused and spontaneous impulsation from vestibular structures is suppressed. Betagistin promotes microcirculation improvement, increases the level of permeability of walls of capillaries, stabilizes indicators of endolymphatic pressure in an inner ear.

At Vestibo's treatment the condition of patients at whom problems with functioning of a vestibular mechanism are noted improves, intensity and frequency of displays of dizzinesses decreases, manifestations of a sonitus are eliminated. People who suffer from decrease in hearing, note its improvement. Also indirect impact of drug on vessels of an inner ear, increase in a gleam of vessels is noted that as a result leads to improvement of a blood-groove. Vestibo promotes activation of a brain blood-groove.

Means does not worsen concentration of attention, the HP does not influence an organism as somnolent or sedative. Means does not influence secretion of gastrointestinal tract glands, does not interact with H2-histamine receptors. The antiedematous, antiallergic, antiinflammatory effect is expressed poorly and has no clinical value.

Pharmacodynamics and pharmacokinetics

In an organism active ingredient is quickly absorbed, the level of linkng with proteins of plasma low, the maximum concentration is observed 3 hours later after taking the medicine.

It is removed in the form of a metabolite through kidneys for 24 hours. The elimination half-life makes from 2 to 4 hours.

Indications to use of tablets of Vestibo

Such indications to Vestibo's use are defined:

  • disturbances of vestibular and labyrinth character (pain and sonitus, dizzinesses, headaches, deterioration in hearing, faints, vomiting and nausea, disturbance of space orientation and balance);
  • edema of a labyrinth of an inner ear;
  • the vestibular dysfunction having an infectious etiology;
  • displays of posttraumatic vestibular dysfunction;
  • dizzinesses of high-quality character which are shown after surgical interventions;
  • Menyer's illness.

Also drug is used at complex therapy of atherosclerosis of vessels of a brain, posttraumatic encephalopathies, vertebrobazilyarny insufficiency. From what Vestibo's tablets can be applied and in what cases it will be reasonablly, in detail told by the doctor.


Drug cannot be accepted in the following cases:

  • high sensitivity to means components;
  • bronchial asthma, manifestation of bronchospasms;
  • pheochromocytoma;
  • exacerbation of stomach ulcer and duodenum;
  • first trimester of pregnancy;
  • With care medicine is appointed to the children, people suffering from a peptic ulcer, hypotonia and also at pregnancy and chest feeding.

Side effects

Generally means is transferred by the patient well, however there can seldom be by-effects which are, as a rule, expressed poorly. In particular, manifestation of the dispepsichesky phenomena, allergic reactions, a headache is possible.

Application instruction of Vestibo (Way and dosage)

Before the patient begins to take Vestibo's pill, the application instruction of means has to be surely carefully studied. Medicine needs to be drunk, without chewing, to wash down plentifully with liquid. To adult patients drug is appointed in a dosage of 8 or 16 mg from 2 to 4 times a day. The dosage is defined how the patient transfers means how serious the disease, and also from its body weight, age and the general state of health is. In days the maximum dose – 48 mg of drug is admissible, that is it is possible to take a pill in a dosage of 24 mg no more than 2 times every day.

The application instruction of Vestibo provides a long course of treatment means. However the final decision on duration of therapy is made by the treating specialist. The notable therapeutic effect will be observed in several months after the beginning of a course of therapy of Vestibo.


At reception of too high doses of drug such symptoms can develop: feeling of heat, a headache, face reddening and bodies in upper part, feeling of heat, dizziness, faints, hypotonia, tachycardia, development of a bronchospasm. In that case it is necessary to cancel at once drug, to carry out a gastric lavage, to apply enterosorbents. If there is such need, the symptomatic treatment is carried out.


At a concomitant use of antihistamines the effect of administration of drug decreases.

Terms of sale

In drugstores means is on sale according to the recipe.

Storage conditions

It is necessary to keep Vestibo at the room temperature, in the dark and dry place.

Period of validity

It is possible to store 3 years Vestibo's tablets of 8 mg and 16 mg, Vestibo's tablet of 24 mg – 2 years.

Special instructions

It is necessary to consider that the expressed influence in the course of therapy appears only several months later after the beginning of a course of treatment to data of HP.


Betaserk, Betaver, Asniton, Betagistin, Mikrozer.

Vestibo's analogs are drugs with similar impact on the patient's organism. These are medicines Vestikap, Asniton, Betaserk, Betaver, Betatsentrin, Mikrozer, Vazoserk, Denoyz, Betagistin, Tagista. The price of analogs is in certain cases lower, than Vestibo's cost however is a number of more expensive drugs.

To children

In the course of research of safety at use of it of HP for children, specialists came to a conclusion that Vestibo is not recommended to be applied to treatment of children.

At pregnancy and a lactation

Today there are no authentic data on how drug influences the developing fruit. Categorically it is impossible to apply Vestibo to treatment in the first weeks of pregnancy, and also during an organogenesis. In the period of the second and third period of pregnancy medicine can be applied only on doctor's orders after it carefully estimates potential advantage and harm of such therapy. In the course of treatment it is important to control the ABP indicators carefully. During feeding by a breast it is necessary to accept drug only after the temporary termination of a lactation. After the end of such treatment it is possible to recover feeding process in 3-5 days after the last reception of Vestibo.

About Vestibo

Coming on a thematic forum and leaving About Vestibo, people in most cases note that after long treatment means notes disappearance of the expressed symptoms, improvement of the general state of health. However there is a number of responses which demonstrates that after treatment the desirable effect was not noted or it disappeared after the end of therapy after a while. Therefore, judging by responses, this drug can effectively remove unpleasant symptoms, but in general the main problem nevertheless remains unresolved. Also as advantages of medicine the acceptable cost, convenience of a dosage (existence of tablets 8, 16 and 24 of mg) is noted it.


  • Vestibo of 16 mg No. 30 of a tablet
  • Vestibo of 24 mg No. 30 of a tablet
  • Vestibo of 8 mg No. 30 of a tablet

Drugstore of IFC

  • Vestibo tbl 8 mg No. 30 *, Aktavis Group Aoislandiya
  • Vestibo tbl 16 mg No. 30, Aktavis Group AO / Katalent Shorndorf Gmbkhgermaniya
  • Vestibo tbl 24 mg No. 30 *, Aktavis Group Aoislandiya
to show still


  • Vestibo20


  • Vestibo of the tab. of 24 mg No. 20aktavis Group
  • Vestibo of the tab. of 24 mg No. 20aktavis Group


  • Vestibo of 8 mg No. 30 of the tab. Balkanfarma-Dupnitsa AD in cooperation with Cardinal Health GmbH 405, Germany (Bulgaria)
  • Vestibo of 24 mg No. 60 of the tab. Aktavis Group, Iceland, proizv. Katalent Germany Shorndorf Gmbh (Germany)
  • Vestibo of 24 mg No. 20 of the tab. Aktavis Group, Iceland, proizv. Katalent Germany Shorndorf Gmbh (Germany)
  • Vestibo of 16 mg No. 30 of the tab. Balkanfarma-Dupnitsa AD in cooperation with Cardinal Health GmbH 405, Germany (Bulgaria)
to show still
Section: For ears Others
in more detail

Education: "Pharmacy" graduated from the Rovno state basic medical college majoring in. Graduated from the Vinnytsia state medical university of M. I. Pirogov and internship on its base.

Experience: From 2003 to 2013 – worked at positions of the pharmacist and manager of a pharmaceutical booth. It is awarded by diplomas and distinctions for long-term and honest work. Articles on medical subject were published in local editions (newspaper) and on various Internet portals.

PAY ATTENTION! Information on drugs on the website is help generalizing, collected from public sources and can form the basis for making decision on use of medicines it is not aware of treatment. Before medicine use of Vestibo surely consult with the attending physician.